MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?


OverviewForecastFinancialsChartTranscripts

MiNK Therapeutics Ownership Summary


MiNK Therapeutics is owned by 0.04% institutional investors, 74.12% insiders, and 25.83% retail investors. Longbow finance sa is the largest institutional shareholder, holding 0.42% of INKT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.38% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMiNK Therapeutics0.04%74.12%25.83%
SectorHealthcare Stocks 279.17%10.51%-189.68%
IndustryBiotech Stocks 63.95%10.67%25.38%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Longbow finance sa166.67K0.42%$116.15K
Renaissance101.71K0.26%$70.88K
Blackrock87.20K0.25%$82.77K
State street25.52K0.06%$17.78K
Goldman sachs group17.56K0.05%$16.67K
Millennium management13.12K0.04%$12.45K
Wells fargo & company/mn10.08K0.03%$7.02K
Bank of america corp /de/2.04K0.01%$1.93K
California state teachers retirement system1.55K0.00%$1.47K
Morgan stanley383.000.00%$363.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Longbow finance sa166.67K0.01%$116.15K
Renaissance101.71K0.00%$70.88K
Game plan financial advisors170.000.00%$116.00
Two sigma securities---
Tower research capital llc (trc)---
Susquehanna group, llp---
Blackrock87.20K-$82.77K
Advisor group---
Assetmark---
Greenwich wealth management---

Top Buyers

HolderShares% AssetsChange
Blackrock87.20K-11.05K
Goldman sachs group17.56K-1.93K
Game plan financial advisors170.000.00%-
Longbow finance sa166.67K0.01%-
State street25.52K--

Top Sellers

HolderShares% AssetsChange
Vanguard group---234.18K
Geode capital management---96.11K
Blackrock funding, inc. /de---88.28K
Hightower advisors---50.68K
Susquehanna group, llp---29.83K

Sold Out

HolderChange
Jaffetilchin investment partners-1.00
Fmr-1.00
Assetmark-1.00
Allworth financial lp-2.00
Harbor investment advisory-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-95.65%16,667-97.94%-1.00%--100.00%1-83.33%
Dec 31, 202423-11.54%809,544-4.38%244.65%6-33.33%6-14.29%
Sep 30, 202426-13.33%846,639-5.78%231.83%9-7-30.00%
Jun 30, 202430-9.09%898,529-4.07%234.90%928.57%10-16.67%
Mar 31, 202433-8.33%936,697-5.46%233.05%7-46.15%1220.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv15.15K0.38%-
Vanguard Institutional Extnd Mkt Idx Tr8.60K0.22%-
Fidelity Extended Market Index5.60K0.14%119.00
iShares Micro-Cap ETF2.01K0.05%-
Fidelity Nasdaq Composite Index1.90K0.05%-
Spartan Extended Market Index Pool E1.38K0.03%1.26K
Spartan Extended Market Index Pool F1.38K0.03%1.26K
Fidelity Series Total Market Index1.34K0.03%178.00
BlackRock Extended Equity Market K8.48K0.02%-4.00
Extended Equity Market Fund K838.000.02%2.00

Recent Insider Transactions


DateNameRoleActivityValue
Oct 16, 2023AGENUS INC-Buy$471.56
Oct 12, 2023AGENUS INC-Buy$3.49K
Oct 13, 2023AGENUS INC-Buy$21.31K
Oct 04, 2023AGENUS INC-Buy$16.38K
Aug 29, 2023AGENUS INC-Buy$45.02K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

INKT Ownership FAQ


Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 0.04%, followed by 74.12% insiders and 25.84% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 63.95%, which MiNK Therapeutics falls below.

Who owns the most shares of MiNK Therapeutics?

MiNK Therapeutics’s largest shareholders are Longbow finance sa (166.67K shares, 0.42%), Renaissance (101.71K shares, 0.26%), and Blackrock (87.2K shares, 0.25%). Together, they hold 0.93% of MiNK Therapeutics’s total shares outstanding.

Does Blackrock own MiNK Therapeutics?

Yes, BlackRock owns 0.25% of MiNK Therapeutics, totaling 87.2K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 82.77K$. In the last quarter, BlackRock increased its holdings by 11.05K shares, a 14.51% change.

Who is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested?

Longbow finance sa is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 166.67K MiNK Therapeutics shares, valued at 116.15K$.

Who is the top mutual fund holder of MiNK Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MiNK Therapeutics shares, with 0.38% of its total shares outstanding invested in 15.15K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools